Evidence map›Paper›PMID 35852733›Full record

ArticleEJNMMI radiopharmacy and chemistry2022

Core-shell structured gold nanoparticles as carrier for

Runze Wang, Bernard Ponsard, Hubert Wolterbeek, Antonia Denkova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. The radioactiveRSC advances · 2025
    Article
  2. Scientific reports · 2025
    Article
  3. EJNMMI radiopharmacy and chemistry · 2024
    Article
  4. Au@EJNMMI radiopharmacy and chemistry · 2023
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Runze WangApplied Radiation and Isotopes, Department of Radiation Science and Technology, Faculty of Applied Sciences, Delft University of Technology, Mekelweg 15, 2629 JB, Delft, The Netherlands.
Bernard PonsardBelgian Nuclear Research Centre, SCK CEN, Boeretang 200, 2400, Mol, Belgium.
Hubert WolterbeekApplied Radiation and Isotopes, Department of Radiation Science and Technology, Faculty of Applied Sciences, Delft University of Technology, Mekelweg 15, 2629 JB, Delft, The Netherlands.
Antonia DenkovaApplied Radiation and Isotopes, Department of Radiation Science and Technology, Faculty of Applied Sciences, Delft University of Technology, Mekelweg 15, 2629 JB, Delft, The Netherlands. A.G.Denkova@tudelft.nl.ORCID http://orcid.org/0000-0002-9367-4121

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadionuclide therapy (RNT) has become a very important treatment modality for cancer nowadays. Comparing with other cancer treatment options, sufficient efficacy could be achieved in RNT with lower toxicity. β

resultsThe

conclusionWe developed a chelator-free radiolabelling method for

Indexed as

Dysprosium-166Gold nanoparticleHolmium-166Internal conversionIn vivo generatorRadionuclide therapy

Identifiers

PMID35852733
PMCPMC9296738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.